Stanford Depression Research Clinic Currently Recruiting for ASCERTAIN-TRD Study
Augmentation versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-Responders with Treatment Resistant Depression (ASCERTAIN-TRD)
The Stanford Depression Research Clinic is seeking people with major depressive disorder (MDD) to participate in a new research study. If you are between the ages of 18 and 80, currently depressed, and have a history of trying at least one antidepressant medication, you may be eligible.
This study involves comparing three treatment arms:
- Adding Abilify to current antidepressant medication
- Adding Repetitive Transcranial Magnetic Stimulation (rTMS) to current antidepressant medication
- Switching your current antidepressant medication to Effexor Extended Release or Cymbalta
These three treatments are approved by the FDA to treat TRD. If enrolled, this study involves 9 visits over 12 weeks.
For further details, please see the following link: https://clinicaltrials.gov/ct2/show/NCT02977299
Full event information: http://events.stanford.edu/events/868/86824
Location: 401 Quarry Road, Stanford CA
Contact Email: firstname.lastname@example.org